Epicore BioNetworks Inc. Announces Board Director Changes and Stock Option Grants

CALGARY, May 5 /CNW/ - The Board of Directors of Epicore BioNetworks Inc. is pleased to announce a new director has joined the board, effective April 23, 2011.  The Board welcomes Mr. Robert S. Poulton of Seattle, WA, USA.

Mr. Poulton is Senior Vice President for Global Quality for Dendreon Corporation of Seattle, WA. He has over twenty-five years of experience in production, quality assurance and regulatory compliance in the pharmaceuticals industry.  He has held officer and board positions and worked in several world areas.   Mr. Poulton holds an honors degree in applied chemistry from Brighton Polytechnic.  The Board expects that his knowledge and experience, particularly in the area of production and quality will be of great benefit to Epicore as it embarks on a more aggressive infrastructure improvement program and completes its ISO-9001:2008 registration program.

The Board of Directors has approved issuance to Mr. Poulton of 200,000 options to buy Epicore common shares.  Additionally, 100,000 options were issued to non-executive directors of the company.  The grants follow Company board compensation policy.  The options being issued have an exercise price of Cdn $0.12 per share and expire in five years.  The 300,000 options granted is equivalent to 1.3% of Epicore's issued common stock. Under the terms of the Epicore Stock Option Plan, which was approved by shareholders at the Company's Annual General and Special Meetings of Shareholders, options may be issued from time to time in any amount up to a maximum of 4,704,246.

The Board of Directors also announces the resignation of Mr. Michael Perrault from the board effective April 12, 2011.  Mr. Perrault faithfully served the board since October 2008.  The Board of Directors thanks him for his service and wishes him the best in his future activities.

Epicore BioNetworks Inc. is a leading producer of environmental biotechnology and animal nutrition products.  It manufactures in the USA and markets worldwide to a variety of industries to reduce environmental pollution and increase operational productivity.

Epicore BioNetworks Inc. is a public corporation with a registered office in Calgary, Alberta, Canada and with shares listed on the TSX Venture Exchange (symbol EBN).  [The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.]

This press release contains forward-looking statements that involve significant risks and uncertainties.  The actual results, performance or achievements of the Company might differ materially from the results, performance or achievements of the Company expressed or implied by such forward-looking statements.  Such forward-looking statements include, without limitation, those regarding the development plans of the Company and the expected timing and results of such development.  We can provide no assurance that such development will proceed as currently anticipated or that the expected timing or results of such development will be realized.  We are subject to various risks, including the uncertainties of product development, markets for our products and regulatory review, our need for additional capital to fund our operations, our reliance on collaborative partners, our history of losses, and other risks inherent in the biotechnology industry.

SOURCE Epicore BioNetworks Inc.

For further information:

Mr. William P. Long (Chief Executive Officer) Tel: 609-267-9118

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890